Clinical Trials Browser

Phase 2 × cedazuridine × Other hematologic neoplasm × Clear all

NCT05799079 2026-01-09

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Phase 2 Terminated

1 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute